CircoMax Myco
Active substance
ATC code
Species
Pigs (for fattening).
Indications
Active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with PCV2 infection. Protection was demonstrated against porcine circovirus types 2a, 2b and 2d.
Active immunisation of pigs against Mycoplasma hyopneumoniae to reduce the lung lesions associated with Mycoplasma hyopneumoniae infection.
Onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.
Duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.
In addition, vaccination has been shown to reduce body weight gain losses under field conditions.
Dose to be administered and administration route
Vaccinate pigs by the intramuscular route in the neck behind the ear.
Single dose vaccination schedule
A single dose of 2 ml in pigs from 3 weeks of age.
Split dose vaccination schedule
Two injections each of 1 ml in pigs from 3 days of age with an interval of approximately 3 weeks.
Choice of dosing regimen, including age of vaccination should take into account farm circumstances. In situations where the level of maternally-derived antibodies against PCV2 is expected to be moderately high or very high, it is recommended to use the split dose vaccination schedule or to delay the age of vaccination.
Shake well before administration and intermittently during the process of vaccination.
The use of a multi-dosing syringe is recommended. Use vaccination devices according to the manufacturer’s instructions. The vaccine is to be administered aseptically. During storage, a slight black deposit may appear, and the emulsion may separate into two distinct phases. Upon shaking, the black deposit disappears, and the emulsion becomes homogenous again.
Adverse reactions
Pigs for fattening:
|
Very common (>1 animal / 10 animals treated): |
Elevated temperature (< 2.1 °C, resolving within 24 hours) |
|
Common (1 to 10 animals / 100 animals treated): |
Injection site swelling (< 2 cm in diameter; for up to 10 days)a |
|
Uncommon (1 to 10 animals / 1,000 animals treated): |
Erythema (in first 24 hours) Hypersensitivity reactions: vomiting, incoordination, lethargy, and laboured breathing (most recover within 24 hours) |
a In a laboratory study, a post-mortem examination of the injection site, performed 2 weeks after the administration of a repeated single dose of the vaccine, very commonly revealed a mild lymphocytic-granulomatous inflammatory response.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See also the last section of the package leaflet for respective contact details.
